Evidence map›Paper›PMID 36363754›Full record

ReviewMicroorganisms2022

Functionalized Noble Metal Nanoparticles for the Treatment of Herpesvirus Infection.

Martyna Janicka, Katarzyna Ranoszek-Soliwoda, Grzegorz Chodaczek, Małgorzata Antos-Bielska, Marek Brytan, Emilia Tomaszewska, Grzegorz Celichowski, Jarosław Grobelny, Joanna Cymerys, Małgorzata Krzyżowska and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. In Vitro Antiviral Activity ofInternational journal of molecular sciences · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Martyna JanickaMilitary Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
Katarzyna Ranoszek-SoliwodaDepartment of Materials Technology and Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163 St., 90-236 Lodz, Poland.ORCID 0000-0001-8522-3593
Grzegorz ChodaczekBioimaging Laboratory, Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wroclaw, Poland.
Małgorzata Antos-BielskaMilitary Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.ORCID 0000-0002-5382-6995
Marek BrytanMilitary Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
Emilia TomaszewskaDepartment of Materials Technology and Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163 St., 90-236 Lodz, Poland.
Grzegorz CelichowskiDepartment of Materials Technology and Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163 St., 90-236 Lodz, Poland.ORCID 0000-0002-1624-3088
Jarosław GrobelnyDepartment of Materials Technology and Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163 St., 90-236 Lodz, Poland.
Joanna CymerysDivision of Microbiology, Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-786 Warsaw, Poland.ORCID 0000-0002-5273-3930
Małgorzata KrzyżowskaMilitary Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.ORCID 0000-0002-8409-3974
Marcin ChodkowskiMilitary Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
University of Łódź · PLWojskowy Instytut Higieny i Epidemiologii · PLWarsaw University of Life Sciences · PLŁukasiewicz Research Network – PORT Polish Center for Technology Development · PL

Funding

Polish National Science Centre 2018/31/B/NZ6/02606
6 · The paper itself

Abstract

Neuroinfections caused by herpesviruses, mainly by HHV-1, represent a significant problem for modern medicine due to the small number of therapeutic substances available in the pharmaceutical sector. Furthermore, HHV-1 infection has been linked to neurodegenerative processes such as Alzheimer's disease, which justifies the search for new effective therapies. The development of nanotechnology opens up new possibilities for the treatment of neuroinflammation. Gold and silver nanoparticles are gaining popularity, and the number of clinical trials involving metallic nanoparticles is constantly increasing. This paper reviews the research on gold and silver nanoparticles and their potential use in the treatment of herpesvirus neuroinfection.

Indexed as

HHV-1neuroinfectionnoble metal nanoparticles

Identifiers

PMID36363754
PMCPMC9695377
OpenAlexW4307989684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.